We found that the Akt-mTOR pathway is hyperactivated in glioma tissues (Fig. 5a, b), where the expression of JMJD2A was also high (Fig. 1a–c), indicating that JMJD2A is related to mTOR activation. The gene discussed is MTOR; the disease is central nervous system cancer.